• AD Eye

    CDD signs a licensing agreement for its technology for early detection of Alzheimer's disease

    Center for Drug Design (College of Pharmacy, University of Minnesota) has signed an agreement to collaborate with medical imaging startup RetiSpec to commercialize the technology for early detection of Alzheimer’s disease. Read More

  • Photo by Greta Kaul
    Photo by Greta Kaul

    Patently lucrative: the intellectual property that makes big money for the U

    Compounds developed in Robert Vince’s University of Minnesota lab to combat the HIV virus made the University more than $600 million dollars. Read More

  • Salomon Bell Slider

    Prof Salomon helps Bell Museum conceptualize an interactive exhibit

    Prof. Christine Salomon worked with staff from the Bell Museum at the University of Minnesota to help conceptualize an interactive exhibit in the Solutions Studio. One of the goals was to engage the public with the creativity and engineering needed to do scientific field research. In the "Stretch your thinking" exhibit, visitors are challenged to think about how to develop a sampling device to reach distant surfaces, much like these researchers need to swab bats that are high up on cave ceilings. See More

  • Profs Vince and More

    Seeing Alzheimer's disease

    A retinal scan technique, developed by researchers in the University’s Center for Drug Design (CDD), has the potential to detect AD in its early stages, when treatment may still be possible, and also to allow doctors to trace the progress of treatments and help the 100,000 Minnesotans with AD and their families. Read More

Message from the Director

Robert Vince

Robert Vince, PhD

The Center for Drug Design (CDD) was created to combine research and scholarship leading to the development of novel drugs for therapeutic applications, such as HIV, cancer, neurological diseases, dermatological agents, infectious diseases, novel processes, and medical devices. The Center for Drug Design combines the best of academic tradition along with an expectation of innovation and independence, and provides significant value  for our academic and research community.

Next Seminar

Keery McPhail
Associate Professor, Director of Graduate Programs
Department of Pharmaceutical Sciences
Oregan State University
Wednesday, October 17, 2018 - 10:00am

3-100 Mayo Atrium

10:00 AM - 11:00 AM

Title: Targeting Inhibitors of Protein Secretion from Microbial Communities

Detecting Alzheimer's with an Eye Exam: Video

Detecting Alzheimer's with an Eye Exam